the aid library

LIST OPTIONS

Filter

14418

Responding to communicable and noncommunicable diseases: progress report 2020-2022

World Health Organization WHO (2023) C_WHO

Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of... more

Guidance for country validation of viral hepatitis elimination and path to elimination

World Health Organization WHO (2023) C_WHO

Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig... more

Download (215)

View PDF (196)

Policy brief on tuberculosis-associated disability

World Health Organization WHO (2023) C_WHO

People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ... more

Download (156)

View PDF (165)

Pre-referral treatment with rectal artesunate of children with suspected severe malaria: a field guide

World Health Organization WHO (2023) C_WHO

Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a... more

Download (287)

View PDF (384)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Zanzibar's victory against Cholera Epidemic

World Health Organization WHO (2023) C_WHO

Response to the Periodic Epidemic

National Strategic Plan for Ending TB 2020-2024

World Health Organization WHO (2023) C_WHO

World Health Organization. Country Office for Timor-Leste. (‎2020)‎. National strategic plan for ending TB 2020--2024. World Health Organization. Country Office for Timor-Leste.

Download (144)

View PDF (131)

Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV

World Health Organization WHO (2023) C_WHO

This updated manual provides a basic understanding of the principles of laboratory and point-of-care (POC) testing in the context of screening and diagnostic approaches, as well as antimicrobial susceptibility testing, as components of sexually transmitted infections (STIs) control. As with previous... more

Opportunities for transition to clean household energy in Nepal

World Health Organization WHO (2023) C_WHO

According to the 2016 Nepal Demographic and Health Survey, 66% of Nepali households use mainly solid fuel for cooking on inefficient stoves. Incomplete fuel combustion of solid fuels emits greenhouse gases and harmful smoke, contributing to climate change, forest degradation, ill health and preventa... more

Country case study: Lao National WASH Survey 2021

World Health Organization WHO (2021) C_WHO

This report describes the results of the Lao People's Democratic Republic (LAO PDR) National WASH Survey 2021. The survey examined water, sanitation and hygiene (‎WASH)‎ and waste management services, as well as climate resilience, in Lao PDR health-care facilities. The survey reveals that while... more

External Link (302)

Bringing high-impact, good-quality and low-cost eye care closer to home: a case study of Klinik Katarak-Kementerian Kesihatan Malaysia

World Health Organization WHO (2023) C_WHO

Health innovation is the creation and implementation of novel processes, products, programmes, policies or systems that lead to transformations or improvements in health and equity. This is the first instalment of "Innovation for Health," a knowledge product series dedicated to showcasing health inn... more

Nudging populations towards healthier eating behaviours: an innovative case study on salt reduction in China

World Health Organization WHO (2023) C_WHO

To address the health challenges brought about by the changing food environment and high salt intake, WHO China, jointly with the National Institute for Nutrition and Health of China CDC and Tsinghua University, conducted an innovative study that applied nudge-based interventions to promote lower sa... more

Download (135)

View PDF (135)

Optimisation du programme des services de santé communautaire en Éthiopie : stratégies pour relever les défis liés au personnel de santé

World Health Organization WHO (2023) C_WHO

Le programme des services de santé communautaire sert de programme phare pour la prestation des soins de santé primaires en Éthiopie. Cependant, sa mise en œuvre s’est heurtée à divers obstacles au niveau du système de santé. En présentant des stratégies porteuses de transformation, la... more

Armenia refugee response: situation report No. 6, 27 November 2023

World Health Organization WHO (2023) C_WHO

Situation update

Armenia Emergency Refugee Response Inter-Agency Update, 15 November - 21 November 2023

World Health Organization WHO Reliefweb OCHA (2023) C_WHO

At the moment, 83 elderly people are receiving care in six round-the-clock care facilities, 17 of them are from the Stepanakert nursing home, 50 are single. As of September 24, 10 children, 5 girls and 5 boys, aged 1 to 17, living in Stepanakert boarding house were also transferred to a round-the-cl... more

HIV epidemic and response in Latin America and the Caribbean. October 2023

World Health Organization WHO (2023) C_WHO

HIV epidemic and response in Latin America and the Caribbean: PPT

Download (254)

View PDF (261)

A checklist for respiratory pathogen pandemic preparedness planning

World Health Organization WHO (2023) C_WHO

This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.

Download (48)

View PDF (61)

Men and HIV: evidence-based approaches and interventions

World Health Organization WHO (2023) C_WHO

Men experience increased risk of morbidity and mortality across all ten major contributors to poor health and continue to lag behind women regarding HIV services and other health outcomes. Globally, men now account for the majority of new HIV infections. In 2022, only 72% of men living with HIV (age... more

Hypertension (high blood pressure)

World Health Organization WHO (2019) C_WHO

Document provides basic information on Hypertension (symptoms, risk factors, complications, treatment) in a descriptive way.

Quit tobacco

World Health Organization WHO (2019) C_WHO

The document provides inforation on tobacco use (health effects, quitting, benefits of quitting, e-cigarettes etc.) in a descriptive way.